Exubera
Trovati 6 articoli
- Exubera linked to lung carcinoma
- Pfizer has informed that it has updated the US product labeling for Exubera ( Insulin human ) Inhalation Powder to include a warning with safety information about lung carcinoma cases observed in patients who used Exubera. This update is based on an ongoing review of the data from the Exubera... (Leggi Articolo)
- Exubera, an inhaled powder form of recombinant human Insulin, associated with lung cancer
- The Exubera label has been updated by Pfizer and FDA ( Food and Drug Administration ). The update resulted from Pfizer and FDA ’s safety reporting and review processes related to clinical trials program and post-marketing reports. A new Warning was added to the Exubera prescribing information ... (Leggi Articolo)
- Diabetes: Exubera, no evidence available of an additional therapeutic benefit
- IQWiG, The German Institute for Quality and Efficiency in Health Care, has published a comparative review of inhaled Insulin ( Exubera ) versus Insulin administered subcutaneously. There is currently no evidence available that Exubera in diabetes therapy shows advantages over short-acting huma... (Leggi Articolo)
- Inhaled powder form of recombinant human Insulin, Exubera approved by FDA
- The FDA ( Food and Drug Administration ) has approved the first ever inhaled Insulin. Exubera, an inhaled powder form of recombinant human Insulin ( rDNA ) for the treatment of adult patients with type 1 and type 2 diabetes, is the first new Insulin delivery option introduced since the discovery ... (Leggi Articolo)
- Type 1 and 2 diabetes: Exubera appears safe and effective
- Results from three two-year studies showed that Exubera ( Human Insulin Powder ), an inhalable, short-acting, dry powder Insulin, provided effective, sustained glycemic control and was well tolerated over two years in adults with type 2 diabetes. A fourth study showed that three months of Exuber... (Leggi Articolo)
- CHMP has recommended approval of Exubera, an human Insulin
- The Committee for Medicinal Products for Human Use of the European Medicines Agency ( CHMP ) issued a positive opinion recommending approval of Exubera ( human Insulin ), an inhalable form of insulin, for the treatment of type 1 and type 2 diabetes. The proposed therapeutic indication for Exub... (Leggi Articolo)
